The US dietary supplement industry begins 2023 watching Congress for signs of support among lawmakers for granting the Food and Drug Administration an authority which has generated disagreement in the industry.
Chief executives of OTC drug and supplement industry trade groups recently discussed questions about potential market and regulatory
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?